Development and application of early precise diagnosis and treatment and follow-up monitoring system in VHL-hemangioblastoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037679

Enrollment

Unknown

Registered

2020-08-30

Start date

2020-08-29

Completion date

Unknown

Last updated

2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VHL-hemangioblastoma

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

7 Years to 70 Years

Inclusion criteria

Inclusion criteria: all VHL-hemangioblastomas

Exclusion criteria

Exclusion criteria: nil

Design outcomes

Primary

Measure	Time frame
VHL gene;	—

Countries

China

Contacts

Public ContactMa Dexuan

Huashan Hospital of Fudan University

madexuan03@126.com+86 18019080638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026